Search

everythinglearnresearchcommunity

for

Search:↓

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Tofacitinib taken by mouth helps treat hair loss in children.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Adverse reactions to isotretinoin in acne treatment are common and mainly linked to treatment duration.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Dupilumab can both heal and cause hair loss.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.